脯氨酰内肽酶对乳糜泻的麦胶蛋白肽解毒作用有限

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

脯氨酰内肽酶对乳糜泻的麦胶蛋白肽解毒作用有限Matysiak-Budnik T.;Candalh C.;Cellier C.;孟欣颖
【期刊名称】《世界核心医学期刊文摘:胃肠病学分册》
【年(卷),期】2006(0)1
【摘要】Background& Aims: The resistance of prolamines to digestive enzymes is thought to be a key contributor to the pathogenesis of celiac disease by promoting the intestinal entrance of peptides able to trigger inflammation in at- risk individuals. Oral administration of a bacterial prolyl- endopeptidase (PEP) therefore was proposed as a treat- ment for celiac disease. To delineate the feasibility of this treatment, the effect of PEP on gliadin peptides was assessed in vitro, and ex vivo during their transport across intestinal biopsy specimens of active celiac disease patients. Methods: In vitro degradation by PEP of 3H- labeled gliadin peptides 56- 88 (33- mer) and 31- 49, was analyzed by radio- reverse- phase high- performance liquid chromatography and mass spectrometry. For ex vivo studies, PEP and 3H- peptides were added together onto the mucosal side of duodenal biopsy specimens mounted in Ussing chambers, and peptide transport and digestion were assessed by radio- reverse- phase high- performance liquid chromatography. Results: Gliadin peptides were degraded partly by 20 mU/mL PEP both in vitro and ex vivo. This concentration of PEP decreased the amount of intact peptides 31- 49 and 56- 88 crossing the intestinal biopsy specimens of celiac disease patients,
but could not prevent the intestinal passage of toxic or immunostimulatory metabolites. PEP concentrations of at least 500 mU/mL for 3 hours were required to achieve full detoxification of peptides and to prevent intestinal transport of active fragments. Conclusions: After prolonged exposure to high concentrations of PEP, the amount of immunostimulatory gliadin peptides reaching the local immune system in celiac patients is decreased. These results provide a basis to establish whether such conditions are achievable in vivo.
【总页数】2页(P25-26)
【关键词】乳糜泻;麦胶蛋白;解毒作用;内肽酶;氨酰;肠黏膜;体外试验;黏膜面;高效液相色谱法;醇溶蛋白
【作者】Matysiak-Budnik T.;Candalh C.;Cellier C.;孟欣颖
【作者单位】INSERM EMI-0212, Faculté Necker-Enfants Malades, 156 rue de Vaugirard, 75730 Paris, France Dr.
【正文语种】中文
【中图分类】R574.62
【相关文献】
1.小麦α-麦醇溶蛋白中致乳糜泻肽段的研究进展 [J], 于凤莲;李素云;袁娟丽;陈红兵;高金燕
2.非酒精性脂肪性肝病小鼠肝组织脯氨酰内肽酶蛋白及其活性变化 [J], 李梦婷;李兵航;周达;丁永年;陈源文;范建高
3.利用坛紫菜藻红蛋白制备脯氨酰内肽酶抑制肽 [J], 谢雪琼; 钟婵; 孙乐常; 翁凌;
张凌晶; 刘光明; 曹敏杰
4.乳糜泻及非乳糜泻性麦胶敏感症 [J], Benjamin Lebwohl; Jonas F Ludvigsson; Peter H R Green; 夏志伟
5.重组人白介素-10抑制乳糜泻患者肠黏膜体外培养物中麦胶蛋白依赖性T细胞的活性 [J], Salveti V.M.;Mazzarella G.;Gianfrani C.;Prof. R. Troncone;雒向宁
因版权原因,仅展示原文概要,查看原文内容请购买。

相关文档
最新文档